全文获取类型
收费全文 | 84245篇 |
免费 | 7685篇 |
国内免费 | 3175篇 |
专业分类
耳鼻咽喉 | 258篇 |
儿科学 | 967篇 |
妇产科学 | 559篇 |
基础医学 | 4386篇 |
口腔科学 | 1026篇 |
临床医学 | 7931篇 |
内科学 | 10430篇 |
皮肤病学 | 1420篇 |
神经病学 | 3100篇 |
特种医学 | 1180篇 |
外国民族医学 | 9篇 |
外科学 | 3794篇 |
综合类 | 10687篇 |
现状与发展 | 8篇 |
一般理论 | 3篇 |
预防医学 | 5302篇 |
眼科学 | 822篇 |
药学 | 35020篇 |
35篇 | |
中国医学 | 3933篇 |
肿瘤学 | 4235篇 |
出版年
2024年 | 285篇 |
2023年 | 1420篇 |
2022年 | 2292篇 |
2021年 | 3187篇 |
2020年 | 3032篇 |
2019年 | 2926篇 |
2018年 | 2988篇 |
2017年 | 3197篇 |
2016年 | 2968篇 |
2015年 | 3039篇 |
2014年 | 5190篇 |
2013年 | 8277篇 |
2012年 | 5309篇 |
2011年 | 5611篇 |
2010年 | 4452篇 |
2009年 | 3893篇 |
2008年 | 3784篇 |
2007年 | 3841篇 |
2006年 | 3340篇 |
2005年 | 3021篇 |
2004年 | 2669篇 |
2003年 | 2373篇 |
2002年 | 1839篇 |
2001年 | 1725篇 |
2000年 | 1433篇 |
1999年 | 1201篇 |
1998年 | 1072篇 |
1997年 | 1055篇 |
1996年 | 880篇 |
1995年 | 860篇 |
1994年 | 751篇 |
1993年 | 655篇 |
1992年 | 695篇 |
1991年 | 613篇 |
1990年 | 570篇 |
1989年 | 463篇 |
1988年 | 448篇 |
1987年 | 414篇 |
1986年 | 364篇 |
1985年 | 439篇 |
1984年 | 404篇 |
1983年 | 285篇 |
1982年 | 345篇 |
1981年 | 252篇 |
1980年 | 228篇 |
1979年 | 197篇 |
1978年 | 159篇 |
1977年 | 167篇 |
1976年 | 131篇 |
1975年 | 121篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
KILL AND CURE THE HOPE AND REALITY OF VIRUS INACTIVATION 总被引:2,自引:0,他引:2
CHRISTOPHER PROWSE 《Vox sanguinis》1994,67(S3):191-196
92.
Adultacuteleukemia (AL)isoneofthemostcommonmalignanttumorsofhematology .Withtherecentprogressinchemotherapyandsupportivether apy ,theremissionandsurvivalrateinALhavebeenmarkedlyimproved .However ,drugresistanceandrelapsearestillimportantfactorsaffectinglongsur vivalofthese patients .Theabnormalregulationofcellcycleisanotherfactorthatcannotbeignoredex ceptformultipledrugresistance (MDR) .WedetectcyclinA ,multidrugresistantgene (mdrl) ,topoiso meraseⅡα(TopⅡα)andbcl 2inadultpatientswithA… 相似文献
93.
D. M. F. Edwards C. Pellizzoni H. P. Breuel A. Berardi M. G. Castelli E. Frigerio I. Poggesi M. Rocchetti A. Dubini M. Strolin Benedetti 《Biopharmaceutics & drug disposition》1995,16(6):443-460
The pharmacokinetics of reboxetine, a new antidepressant agent, were found to be close to linear in a crossover study comparing administration of single 2, 3, 4 and 5 mg capsule doses in 15 healthy male volunteers, and in the same study the capsules were bioequivalent to the proposed therapeutic tablet formulation (4mg). Kinetic analysis was based on HPLC assay of reboxetine in plasma and urine collected up to 72 h after each administration. Plasma levels indicated a rapid absorption (tmax?2h) and an elimination half-life of about 13 h. Clearance and volume of distribution were modest (ratios to bioavailability: CL/F?29 mL min?1; Vz/F?32L); urinary excretion was ~9% of dose, corresponding to a renal clearance of only 3 mL min?1 (a value consistent with the rate of glomerular filtration of unbound drug). In vitro, binding to plasma proteins, estimated from radioactivity levels following dialysis of 14C-labelled reboxetine, appeared to be dominated by α1-acid glycoprotein without marked saturation up to plasma concentrations of over 500 ng mL?1 (2.8–3.1% unbound with human plasma from three additional volunteers; 1.8–2.0% for 2gL?1 orosomucoid α1-acid glycoprotein, and 46.4–47.4% for 40 gL?1 albumin), whilst the mean Cmax in the current study was much lower (164 ng mL?1 after a 5 mg dose). 相似文献
94.
95.
In a sample of 55 consecutive methadone maintenance admissions to our clinic, 42% were diagnosed with antisocial personality disorder (ASPD) using the National Institute of Mental Health Diagnostic Interview Schedule NIMH DIS. Individuals with ASPD exhibited greater risk for HIV infection as defined by more sexual contacts, needle use and equipment sharing. Data at 1 year follow-up were obtained on this group of patients. The objective was to compare the ASPD and non-ASPD groups with regards to demographics, drug abuse history, outcome and retention in treatment. There were no significant differences between the groups on any demographic or treatment outcome variables. Survival analysis indicated that there were no group differences in treatment retention. In conclusion, although there were no differences in treatment outcome between ASPD and non-ASPD groups it is possible that ASPD patients who drop out of treatment will be at higher risk for contracting and spreading HIV within the IV drug using population. These data also suggest that in this population the diagnosis of ASPD using primarily behavioral traits as measured in the NIMH-DIS-III, has little utility in predicting treatment outcome. 相似文献
96.
97.
刘德荣 《福建中医学院学报》2003,13(1):42-44
北宋名医吴本的精湛医术和高尚医德在漳州、泉州和台南民众中久为传颂,流感在慈济宫的“济世仙方药鉴”是现存有关吴本的宝贵医药资料,该药签体现了中医的选方特点和用药特点,今天仍有整理研究的价值。 相似文献
98.
Objective: To study the calcium channel reaction of human Leydig cells induced by hCG/ATP at different extracellular calcium ion concentrations. Methods: The Leydig cell calcium ion concentration was examined with laser confocal microscope, when the cells were stimulated with hCG/ATP at different extracellular calcium contrations. Results: With calcium-containing extracellular fluid, the Leydig cells were sensitive to hCG stimulation and when the extracellular fluid was calcium-free, the Leydig cells did not respond to the stimulation. However, the Leydig cells did respond to ATP stimulation no matter the extracellular fluid contained calcium or not. Conclusion: In human Leydig cells, there are calcium channels sensitive to hCG and ATP. The extracellular calcium ion concentration plays an important role in the regulation of Leydig cell metabolism by hCG/ATP. 相似文献
99.
Pharmacokinetics of orally administered hexobarbital in plasma and saliva of healthy subjects 总被引:1,自引:0,他引:1
M van der Graaff N P Vermeulen P Heij J K Boeijinga D D Breimer 《Biopharmaceutics & drug disposition》1986,7(3):265-272
Hexobarbital (HB) concentrations were determined in plasma and saliva of 8 healthy subjects, following oral administration of 500 mg HB-Na. Mean plasma half-lives were 3.2 +/- 0.1 h, and salivary half-lives 3.3 +/- 0.2 h. Mean plasma clearance was 22.9 +/- 2.3 1 h-1. There was a linear relationship between HB concentrations in saliva and plasma (r = 0.92). Mean salivary levels were 34 per cent of plasma levels. Salivary pH was constant throughout the experiment, 7.06 +/- 0.09. There was an inconsistent tendency of the saliva over plasma ratios to increase as a function of time. The percentage of protein binding calculated from saliva over plasma ratios was in reasonable agreement with in vitro data of equilibrium dialysis, 64.1 +/- 2.6 per cent and 65.9 +/- 0.8 per cent, respectively. The experiment was repeated in 4 subjects, and considerable intraindividual differences were shown to exist in saliva over plasma ratio, half-lives, and protein binding. It was concluded that HB elimination half-lives can relatively accurately be determined from salivary concentrations. Oral plasma clearance can only be estimated if the individual saliva over plasma ratios are known; this would require the taking of at least one blood sample during the experiment. When employing HB as a model substrate for drug metabolizing enzyme activity in vivo, the determination of its pharmacokinetic parameters, particularly oral plasma clearance as a reflection of cytochrome P-450 activity, cannot be achieved by taking saliva samples only. 相似文献
100.
G. M. Pacifici A. Viani H. -U. Schulz H. -J. Frercks 《European journal of clinical pharmacology》1987,32(2):199-202
Summary The protein binding of furosemide was investigated in plasma from 22 old and 11 young subjects by equilibrium dialysis. The unbound fraction of furosemide was 3.16% in plasma from the elderly and 1.71% in plasma from the young. A significant correlation was found between the unbound fraction of furosemide and the plasma concentration of albumin. The average number of binding sites was 3.8 (elderly) and 2.7 (young) 10–6 mol/g albumin. The average association constant (K) was 4.3 (elderly) and 4.2 (young) 105 M–1. By increasing the concentration of furosemide up to 200 µg/ml buffer the unbound fraction of the drug rose to 5.2% (elderly) and 3.5% (young). 相似文献